Chemical synthesis cannot keep pace with RNA innovation. Our proprietary ezRNA™ platform builds RNA enzymatically and promises long-term manufacturing solutions to sustainably deliver RNA therapeutics at scale.
01 | Capabilities
Our ezRNA™ platform is flexible and expansive. Solutions range from complete de novo RNA synthesis to single extensions off therapeutic payloads, while accessing enhancements such as site-specific modifications, fluorophores, and clickable handles.
02 | Modifications
Our ezRNA™ platform has the proven capability to incorporate a diverse array of nucleotide modifications – critical for RNA therapeutic viability – including modifications at the sugar, backbone, and base. The platform can provide access to novel modifications that current production methods fails to deliver.
03 | Sustainability
Our ezRNA™ platform enables template-independent synthesis in aqueous-based reaction conditions. This advancement fundamentally eliminates regulated organic solvents and provides better atom economy for sustainable solutions at scale.
Our enzymatic synthesis platform unlocks site-specific and diverse RNA modifications